Literature DB >> 28721572

I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients.

M Voth1, M Duchene2, B Auner2, T Lustenberger2, B Relja2, I Marzi2.   

Abstract

BACKGROUND: Intestinal injury is a rare injury in multiply traumatized patients, and its diagnosis remains difficult. Delayed diagnosis of an intestinal injury increases the risk of sepsis, multiple organ failure and mortality. The intestinal fatty acid-binding protein (I-FABP) is solely expressed in the intestine and is released extracellulary after tissue damage. This study evaluates the validity of I-FABP as an early biomarker to detect an abdominal injury and particularly an injury to the intestine. PATIENTS AND METHODS: Patients with an Abbreviated Injury Scale (AIS) score for abdominal body region (AIS abdomen) ≥3 were included in this study from 07/2006 to 12/2014. Of those, ten patients retrospectively had an intestinal injury (int. injury). According to the Injury Severity Score and the AIS abdomen, corresponding patients with an abdominal injury but without an intestinal injury (no int. injury) were included for matched-pair analysis. Twenty healthy volunteers served as controls. Plasma I-FABP levels were measured at admission to the emergency room and up to 10 days daily (d1-d10).
RESULTS: Median I-FABP levels were significantly higher in the "int. injury" group compared to the "no int. injury" group [2101.0 pg/ml (IQR = 1248.1-4117.8) vs. 351.4 pg/ml (IQR = 287.6-963.3), p < 0.05]. Furthermore, I-FABP levels of both groups were significantly higher compared to the control group [Ctrl: 127.2 pg/ml (IQR = 57.4-310.6), p < 0.05]. The time course of I-FABP levels showed a peak on the day of admission and a decline to the control levels in the further post-traumatic course. The development of complications such as single- or multi-organ failure, sepsis, acute respiratory distress syndrome, pneumonia and mortality was higher in the "int. injury" group; however, this difference was not statistically significant.
CONCLUSION: This study confirmed our previous observation that I-FABP might be used as a suitable early biomarker for the detection of abdominal injuries in general. In addition and more specific, I-FABP may be a useful and promising parameter in the diagnosis of intestinal injuries.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28721572     DOI: 10.1007/s00268-017-4124-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  50 in total

1.  Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction.

Authors:  Daniel R Cronk; Troy P Houseworth; Daniel G Cuadrado; Garth S Herbert; Patrick M McNutt; Kenneth S Azarow
Journal:  Curr Surg       Date:  2006 Sep-Oct

Review 2.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

3.  Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study.

Authors:  F H Heida; J B F Hulscher; M Schurink; A Timmer; E M W Kooi; A F Bos; J L M Bruggink; D C Kasper; M Pones; T Benkoe
Journal:  J Pediatr Surg       Date:  2014-11-21       Impact factor: 2.545

4.  Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury.

Authors:  Borna Relja; Maika Szermutzky; Dirk Henrich; Marcus Maier; Jacco-Juri de Haan; Tim Lubbers; Wim A Buurman; Ingo Marzi
Journal:  Acad Emerg Med       Date:  2010-07       Impact factor: 3.451

Review 5.  Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury.

Authors:  Cangel P Y Chan; Terence S M Wan; Keith L Watkins; Maurice M A L Pelsers; Daniëlle Van der Voort; Francis P W Tang; Kenneth H K Lam; Jürgen Mill; Yvonne Yuan; Matthias Lehmann; Albrecht Hempel; John E Sanderson; Jan F C Glatz; Reinhard Renneberg
Journal:  Biosens Bioelectron       Date:  2004-11-18       Impact factor: 10.618

6.  I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course.

Authors:  Maika Voth; Sebastian Holzberger; Birgit Auner; Dirk Henrich; Ingo Marzi; Borna Relja
Journal:  Clin Chem Lab Med       Date:  2015-04       Impact factor: 3.694

7.  [Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy].

Authors:  K Dalhoff; M Abele-Horn; S Andreas; T Bauer; H von Baum; M Deja; S Ewig; P Gastmeier; S Gatermann; H Gerlach; B Grabein; G Höffken; W V Kern; E Kramme; C Lange; J Lorenz; K Mayer; I Nachtigall; M Pletz; G Rohde; S Rosseau; B Schaaf; R Schaumann; D Schreiter; H Schütte; H Seifert; H Sitter; C Spies; T Welte
Journal:  Pneumologie       Date:  2012-12-06

8.  Hollow visceral injury and blunt trauma.

Authors:  G S Allen; F A Moore; C S Cox; J T Wilson; J M Cohn; J H Duke
Journal:  J Trauma       Date:  1998-07

9.  Prospective comparison of diagnostic peritoneal lavage, computed tomographic scanning, and ultrasonography for the diagnosis of blunt abdominal trauma.

Authors:  M Liu; C H Lee; F K P'eng
Journal:  J Trauma       Date:  1993-08

10.  The accuracy of computed tomography in the diagnosis of blunt small-bowel perforation.

Authors:  J Sherck; C Shatney; K Sensaki; V Selivanov
Journal:  Am J Surg       Date:  1994-12       Impact factor: 2.565

View more
  11 in total

1.  Intestinal Microbial Products From Alcohol-Fed Mice Contribute to Intestinal Permeability and Peripheral Immune Activation.

Authors:  Derrick R Samuelson; Min Gu; Judd E Shellito; Patricia E Molina; Christopher M Taylor; Meng Luo; David A Welsh
Journal:  Alcohol Clin Exp Res       Date:  2019-09-05       Impact factor: 3.455

2.  The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.

Authors:  Yufan Dai; Wenyu Zhu; Jiaxuan Zhou; Tao Shen
Journal:  Braz J Med Biol Res       Date:  2022-05-16       Impact factor: 2.904

3.  Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats.

Authors:  Chang-An Guo; Li Ma; Xiao-Lu Su; Ying-Zhen Wang; Ling-Ling Zhen; Bei Zhang; Hong An; Hong-Bin Liu
Journal:  Turk J Gastroenterol       Date:  2020-04       Impact factor: 1.852

4.  I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV.

Authors:  Lediya T Cheru; Elli A Park; Charles F Saylor; Tricia H Burdo; Kathleen V Fitch; Sara Looby; Jeffrey Weiner; Jake A Robinson; Jane Hubbard; Martin Torriani; Janet Lo
Journal:  Open Forum Infect Dis       Date:  2018-11-05       Impact factor: 3.835

5.  Necroptosis is active and contributes to intestinal injury in a piglet model with lipopolysaccharide challenge.

Authors:  Yulan Liu; Qiao Xu; Yang Wang; Tianzeng Liang; Xiangen Li; Dan Wang; Xiuying Wang; Huiling Zhu; Kan Xiao
Journal:  Cell Death Dis       Date:  2021-01-11       Impact factor: 8.469

6.  A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.

Authors:  Rachel M Presti; Eunice Yeh; Brett Williams; Alan Landay; Jeffrey M Jacobson; Cara Wilson; Carl J Fichtenbaum; Netanya S Utay; Michael P Dube; Karin L Klingman; Jacob D Estes; Jacob K Flynn; Amanda Loftin; Jason M Brenchley; Adriana Andrade; Douglas W Kitch; Edgar T Overton
Journal:  Open Forum Infect Dis       Date:  2021-12-07       Impact factor: 4.423

7.  Intestinal fatty acid-binding protein is a biomarker for diagnosis of biliary tract infection.

Authors:  Yu-Chieh Weng; Wei-Ting Chen; Jung-Chieh Lee; Yung-Ning Huang; Chih-Kai Yang; Hui-Shan Hsieh; Chih-Jung Chang; Yang-Bor Lu
Journal:  JGH Open       Date:  2021-08-20

8.  Acute alcohol consumption increases systemic endotoxin bioactivity for days in healthy volunteers-with reduced intestinal barrier loss in female.

Authors:  Ramona Sturm; Florian Haag; Andrea Janicova; Baolin Xu; Jan Tilmann Vollrath; Katrin Bundkirchen; Ildiko Rita Dunay; Claudia Neunaber; Ingo Marzi; Borna Relja
Journal:  Eur J Trauma Emerg Surg       Date:  2021-04-11       Impact factor: 2.374

9.  Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients?

Authors:  Maika Voth; Thomas Lustenberger; Borna Relja; Ingo Marzi
Journal:  World J Emerg Surg       Date:  2019-11-21       Impact factor: 5.469

10.  The Effects of Exercise on Indirect Markers of Gut Damage and Permeability: A Systematic Review and Meta-analysis.

Authors:  Sarah Chantler; Alex Griffiths; Jamie Matu; Glen Davison; Ben Jones; Kevin Deighton
Journal:  Sports Med       Date:  2021-01       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.